Cowen Inc’s Juno Therapeutics, Inc. JUNO Stock Holding History

Cowen Inc’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-101	Closed	-$224K	–	374
2017 Q1	$224K	Sell	101 -19,999	-99%	-$429K	0.01%	205
2016 Q4	$379K	Buy	+20,100	New	+$492K	0.02%	205
2015 Q4	–	Sell	-27,500	Closed	-$1.12M	–	365
2015 Q3	$1.12M	Buy	+27,500	New	+$1.21M	0.07%	141

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Cowen Inc's JUNO Position: Q1 2018 in Review

Cowen Inc sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 6,750 shares — an estimated $309K sold.

Cowen Inc first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $309K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Cowen Inc reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Cowen Inc sold 6,750 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $309K.
Cowen Inc first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Cowen Inc's Juno Therapeutics, Inc. position peaked at $309K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Cowen Inc's 13F filing for Q1 2018, filed 15 May 2018.